MAA
INSY

Managed Account Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Managed Account Advisors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$885K Buy
24,628
+24,516
+21,889% +$764K ﹤0.01% 2148
2015
Q1 		$3K Buy
+112
New +$2.96K ﹤0.01% 2904

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Managed Account Advisors's INSY Position: Q2 2015 in Review

Managed Account Advisors increased its Insys Therapeutics, Inc. (INSY) stake by 21,889% in Q2 2015, buying an estimated $764K and bringing the position to 24,628 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Managed Account Advisors first reported a position in INSY in Q1 2015 and has held it in 2 quarters since. 146 funds tracked by Wall St. Rank hold INSY as of Q2 2015.

  • Managed Account Advisors held 24,628 shares of Insys Therapeutics, Inc. worth $885K as of Q2 2015.
  • Managed Account Advisors bought 24,516 Insys Therapeutics, Inc. shares in Q2 2015, an estimated $764K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2148 holding.
  • Managed Account Advisors first reported a position in Insys Therapeutics, Inc. in Q1 2015 and has held it in 2 quarters since.
  • 146 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.